The results from a 48-week phase 2 trial in patients with obesity who are at risk of developing cardiovascular diseases, showed that patients had achieved a mean weight loss of 15.6% on a 2.4 mg dose of the drug, and notably, improvements in blood pressure as well as no cardiac event imbalances took place
Bayrer JR, Castro J, Venkataraman A, Touhara KK, Rossen ND, Morrie RD, et al
Retatrutide, a new weight loss drug, is generating buzz for its extensive list of benefits beyond just weight loss
Ensuring adequate calcium, vitamin D, and protein intake, along with weight-bearing exercise, helps preserve bone health during weight reduction
Ro is the only company to offer telehealth and in-home care, diagnostics, labs, and pharmacy services nationwide
Vitamin B12 plays a role in promoting healthy cells in nails, hair, and skin